Selective inhibition of TNF-α-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib

We have reported that the selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, gefitinib (‘Iressa’, ZD1839), suppressed intrahepatic metastasis of hepatocellular carcinoma CBO140C12 cells. In this study, we focused on the tumour necrosis factor-α (TNF-α) signalling pathways....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ueno, Y, Sakurai, H, Matsuo, M, Choo, M K, Koizumi, K, Saiki, I
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2005
Teme:
Translational Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362047/
https://ncbi.nlm.nih.gov/pubmed/15841081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602548
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki